MedPath

Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial

Not Applicable
Completed
Conditions
Pain, Back
Pain, Neuropathic
Chronic Pain
Intractable Pain
Low Back Pain
Interventions
Device: Spinal Cord Stimulation
Registration Number
NCT04909593
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The purpose of the study is to assess the feasibility of using information extracted from physiologic signals to automatically adjust stimulation in patients undergoing Spinal Cord Stimulation (SCS).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Study candidate is undergoing a temporary SCS trial of commercially approved BSC neurostimulator system, per local directions for use (DFU).
  • Subject signed a valid, EC/IRB-approved informed consent form.
  • Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law when written informed consent is obtained.
  • In the clinician best judgment, subject is able to distinguishably describe quality and location of sensation and pain.

Key

Exclusion Criteria
  • Subject meets any contraindication in BSC neurostimulation system local DFU.
  • Investigator-suspected gross lead migration during the SCS trial period which may preclude the study candidate from receiving adequate SCS therapy.
  • Subject is currently diagnosed with cognitive impairment, or exhibits any characteristic, that in the clinician's best judgement would limit study candidate's ability to assess and report sensation information.
  • Subject is currently diagnosed with a physical impairment, or exhibits a condition that would limit study candidate's ability to complete study assessments.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Spinal Cord StimulationSpinal Cord StimulationSCS trial systems including external trial stimulators, lead(s)/extensions(s), and operating room (OR) cable(s)/extender(s) and optional sensor.
Primary Outcome Measures
NameTimeMethod
Perception ThresholdProgramming Visit (up to 15 days post-screening)

Percent change in patient's perceiving spinal cord stimulation (i.e. Perception Threshold) when going from a reclining to sitting position in a reclining chair

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PCPMG Clinical Research Unit, LLC

🇺🇸

Greenville, South Carolina, United States

PCPMG Clinical Research Unit, LLC
🇺🇸Greenville, South Carolina, United States
Boston Scientific Clinical Research Manager
Contact
855-213-9890
BSNClinicalTrials@bsci.com
Eric P Loudermilk, MD
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath